Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
The First People's Hospital of Lianyungang
SARS-CoV-2
1 trial -
SARS-CoV-2 mRNA Vaccine, Bivalent Low dose
The First People's Hospital of Lianyungang
SARS-CoV-2
1 trial -
SBRT
Hospital Authority, Hong Kong
Spine Metastases
1 trial -
SGLT2 inhibitor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Kidney Transplantation
1 trial -
SPECT/CT imaging with 99mTc-P137 nuclide probe
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
SSRI treated group
Samsung Bioepis NL B.V.
Depression
2 trials -
SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Major Depressive Disorder
1 trial -
Sana Device (Control)
Sana Biotechnology
Fibromyalgia
1 trial -
Sapropterin
BioMarin Pharmaceutical Australia Pty Ltd
Hyperphenylalaninemia
1 trial -
Sarcosine
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Secukinumab 300 MG; Tofacitinib 11mg
The First People's Hospital of Lianyungang
Hidradenitis Suppurativa
1 trial -
Selective Serotonin Reuptake Inhibitors (SSRIs)
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Semaglutide
GT Biopharma
Obesity (Disorder)
1 trial -
Senl_B19 autologous CAR-T (S1904) treatment
The First People's Hospital of Lianyungang
Relapsed Adult ALL
1 trial -
Seromycin (D-cycloserine, DCS)
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Addiction
1 trial -
Sertraline plus placebo of JWXYJN
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depressive Disorder
1 trial -
Shenbai Granules
The First People's Hospital of Lianyungang
Colorectal Adenoma
1 trial -
Single dose of 2L PEG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Health Behavior
1 trial -
Single dose of ibuprofen (800 mg tablet)
BRIGHT MINDS BIOSCIENCES INC.
Human Gastrointestinal Physiology Data
1 trial -
Sitz-Markers
United Therapeutics Europe Ltd
Return of Bowel Function After Colon Surgery
1 trial -
Siwu Tang
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Brain Hypoperfusion Syndrome
1 trial -
Sniffing emotional tears
Hospital Authority, Hong Kong
Obesity
1 trial -
Sodium Bicarbonate Ringer's Solution
The First People's Hospital of Lianyungang
Hyperlactacidemia
1 trial -
Solifenacin Succinate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Overactive Bladder
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources